« Back
Home /
Anti-MKI67 antibody (2950-3000) {FITC} (STJ501533)

Anti-MKI67 antibody (2950-3000) {FITC} (STJ501533)

€537.00

Excl. VAT

Item no.	STJ501533-100
Manufacturer	St John's Laboratory
Amount	100 ug
Category	Oncology Neuroscience Neural Lineage Markers Molecular Targets for Neuroscience Neural Development Antibodies By Cell Type Blastoma Carcinoma Hematology Lymphoma Cell Biology Cell Status Immunoprecipitation Western Blot ELISA Proliferation Viability Primary Antibodies By Organ Lung Cancer Bladder Cancer Breast Cancer Testicular & Prostate Cancer Cytoskeleton Markers
Type	Antibody Primary
Conjugate/Tag	FITC
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Available
Clonality	Polyclonal
Conjugation	FITC
Target Name	MKI67
Formulation	Tris/glycine buffer at pH 7.4 containing 0.02% sodium azide as preservative, cryo-protective agents, 0.5% stabilizing protein BSA and 30% glycerol.
Purification	Affinity Purified
Specificity	This antibody will detect both isoform 1 and isoform 2 in human.
Uniprot Id	P46013
Storage Instruction	Store at-20C. Avoid freeze/thaw cycles.
Concentration	0.55-0.75 ug/ul in antibody stabilization buffer
Gene Id	4288
Gene Symbol	MKI67
Immunogen	Synthetic peptide taken within amino acid region 2950-3000 on human antigen Ki67 isoform 1.
Dilution Range	DB 1:10, 000 ELISA 1:10, 000 IP 1:200 WB 1:500
Accession Number	NP_002408.3
Note	FOR RESEARCH USE ONLY (RUO).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

Listprice: €537.00

Price: €537.00

available

Delivery expected until 8/7/2025

Quantity:

Compare